EPC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Edgewell Personal Care Co (EPC) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock lacks significant positive catalysts, and the technical indicators, options data, and financial performance do not strongly support an immediate investment. While analysts have raised price targets slightly, the stock's recent performance and lack of strong trading signals suggest holding off for now.
The technical indicators show a neutral to slightly bearish trend. The MACD is negative and contracting, RSI is at 37.608 (neutral zone), and moving averages are converging. The stock is trading near its support level (S1: 18.931) with resistance at R1: 21.154. There is no clear bullish signal at this time.
Analysts have slightly raised price targets, with Wells Fargo maintaining an Overweight rating and noting improvements in the portfolio after the divestiture of the Feminine Care business. Revenue has increased by 1.85% YoY.
The company's net income remains negative despite a significant YoY improvement. Gross margin has dropped by 5.08% YoY, and EPS remains negative. The stock has shown a pre-market decline of -2.32% and a regular market decline of -1.01%. No recent news or significant trading trends from hedge funds or insiders.
In Q1 2026, revenue increased by 1.85% YoY to $422.8M. However, net income remains negative at -$65.7M, despite a significant improvement of 3028.57% YoY. EPS improved to -1.41, up 3425% YoY, but gross margin dropped to 39.45%, down -5.08% YoY.
Analysts have raised price targets slightly, with Wells Fargo increasing the target to $24 from $22 and maintaining an Overweight rating. Barclays raised its target to $21 from $19, maintaining an Equal Weight rating. Analysts note improvements in the portfolio but highlight the need for better visibility into the second half of 2026.
